Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
EMBO J ; 40(21): e107532, 2021 11 02.
Article in English | MEDLINE | ID: mdl-34549820

ABSTRACT

Astrocytes regulate brain-wide functions and also show region-specific differences, but little is known about how general and region-specific functions are aligned at the single-cell level. To explore this, we isolated adult mouse diencephalic astrocytes by ACSA-2-mediated magnetic-activated cell sorting (MACS). Single-cell RNA-seq revealed 7 gene expression clusters of astrocytes, with 4 forming a supercluster. Within the supercluster, cells differed by gene expression related to ion homeostasis or metabolism, with the former sharing gene expression with other regions and the latter being restricted to specific regions. All clusters showed expression of proliferation-related genes, and proliferation of diencephalic astrocytes was confirmed by immunostaining. Clonal analysis demonstrated low level of astrogenesis in the adult diencephalon, but not in cerebral cortex grey matter. This led to the identification of Smad4 as a key regulator of diencephalic astrocyte in vivo proliferation and in vitro neurosphere formation. Thus, astrocytes show diverse gene expression states related to distinct functions with some subsets being more widespread while others are more regionally restricted. However, all share low-level proliferation revealing the novel concept of adult astrogenesis in the diencephalon.


Subject(s)
Astrocytes/metabolism , Cell Lineage/genetics , Diencephalon/metabolism , Gene Expression Regulation, Developmental , Neurogenesis/genetics , Smad4 Protein/genetics , Animals , Astrocytes/classification , Astrocytes/cytology , Cell Cycle/genetics , Cell Differentiation , Cell Proliferation , Cerebral Cortex/cytology , Cerebral Cortex/growth & development , Cerebral Cortex/metabolism , Diencephalon/cytology , Diencephalon/growth & development , Gene Ontology , Gene Regulatory Networks , Gray Matter/cytology , Gray Matter/growth & development , Gray Matter/metabolism , Metabolic Networks and Pathways , Mice , Mice, Inbred C57BL , Mice, Transgenic , Molecular Sequence Annotation , Multigene Family , Signal Transduction , Smad4 Protein/metabolism
2.
Eur Arch Psychiatry Clin Neurosci ; 270(4): 425-431, 2020 Jun.
Article in English | MEDLINE | ID: mdl-30523404

ABSTRACT

Cognitive deficits are increasingly recognized as a core dimension rather than a consequence of schizophrenia (SCZ). The previous evidence supports the hypothesis of shared genetic factors between SCZ and cognitive ability. The objective of this study was to test whether and to what extent the variation of disease-relevant neurocognitive function in a sample of SCZ patients from the previous clinical interventional studies can be explained by SCZ polygenic risk scores (PRSs) or by hypothesis-driven and biomedical PRSs. The previous studies have described associations of the SNAP25 gene with cognition in SCZ. Likewise, the enrichment of several calcium signaling-related gene sets has been reported by genome-wide association studies (GWAS) in SCZ. Hypothesis-driven PRSs were calculated on the basis of the SNAP-25 interactome and also for genes regulated by phorbol myristate acetate (PMA), an activator of the signal transduction of protein kinase C (PKC) enzymes. In a cohort of 127 SCZ patients who had completed a comprehensive neurocognitive test battery as part of the previous antipsychotic intervention studies, we investigated the association between neurocognitive dimensions and PRSs. The PRS for SCZ and SNAP-25-associated genes could not explain the variance of neurocognition in this cohort. At a p value threshold of 0.05, the PRS for PMA was able to explain 2% of the variance in executive function (p = 0.05, uncorrected). The correlation between the PRS for PMA-regulated genes and cognition can give hints for further patient-derived cellular assays. In conclusion, incorporating biological information into PRSs and other en masse genetic analyses may help to close the gap between genetic vulnerability and the biological processes underlying neuropsychiatric diseases such as SCZ.


Subject(s)
Calcium Signaling/genetics , Cognitive Dysfunction , Executive Function/physiology , Schizophrenia , Adult , Cognitive Dysfunction/etiology , Cognitive Dysfunction/genetics , Cognitive Dysfunction/physiopathology , Cohort Studies , Female , Humans , Male , Multifactorial Inheritance , Schizophrenia/complications , Schizophrenia/genetics , Schizophrenia/physiopathology , Synaptosomal-Associated Protein 25/genetics
SELECTION OF CITATIONS
SEARCH DETAIL